DNDi and MMV, supported by Unitaid, deliver statement about R&D and access to child-friendly medicines at the 71st World Health Assembly
24 May 2018
Geneva, Switzerland
DNDi and MMV, supported by Unitaid, delivered a statement on the progress made by WHO in developing a Global Framework on Nurturing Care for Early Childhood Development. The statement calls for R&D and access to child-friendly medicines, and open data sharing of research findings.
HSB Noticias [6 May 2018]
“Crisis del ‘Chagas’ se agrava en Colombia según el Instituto Nacional de Salud” – “‘Chagas’ crisis worsens in Colombia according to the National Institute of Health”
Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind
by Grillon C, Krishtel PR, Mellouk O, Basenko A, Freeman J, Mendão L, Andrieux-Meyer I, Morin S.
Journal of the International Aids Society, April 2018
Caracol Radio [14 April 2018]
“Minsalud desarrolla acuerdo para garantizar la atención integral de Chagas” – “Ministry of Health develops agreement to guarantee comprehensive Chagas attention”
DNDi agreement with Colombia Ministry of Health and Social Welfare to guarantee access to comprehensive care for Chagas patients
Bogotá, Colombia – 14 April 2018
Objective is to improve access to diagnosis and treatment of people affected by this disease
An agreement to facilitate and strengthen access to diagnosis and treatment of patients with Chagas and other diseases of public health interest has been signed by the Colombian Ministry of Health and Social Protection and the non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi).
Drug approved in Argentina for treatment of Chagas disease in children
Buenos Aires, Argentina – 13 April 2018
Argentina has approved the paediatric indication of a drug used for treatment of Chagas disease, benznidazole, which will now be available in 12.5 mg pills, the dose required to treat children under the age of 2. The indication was approved by the Argentinian National Administration for Drugs, Food, and Medical Technologies (ANMAT).
18th World Congress of Basic and Clinical Pharmacology
1-6 July 2018
Kyoto, Japan
Tatsuro Kuzuki, Scientific Liaison, DNDi Japan – session on NTDs
Affordable Medicines Now
27-29 June 2018
Washington DC, USA
Rachel Cohen, Regional Executive Director – session on global struggles for affordable medicines
ISNTD d³ 2018
25-26 June 2018
London, UK
Ivan Scandale, Senior Project Manager, Discovery – presentation on the filarial research landscape
Eric Stobbaerts, International Development Director – presentation on access to Chagas treatments in Latin America
VTV [3 April 2018]
“Chi phí điều trị viêm gan C sẽ giảm mạnh tại Mỹ Latinh” – “The cost of treatment for hepatitis C will drop sharply in Latin America”
DIA Europe 2018
17-19 April 2018
Basel, Switzerland
Nathalie Strub-Wourgraft, DNDi Medical Director – Member of multi-stakeholder panel: “Towards access 2030: How can strengthening of regulatory systems contribute?”